Mechanism of Protective Actions of Sparsentan in the Kidney: Lessons From Studies in Models of Chronic Kidney Disease
Clinical Science – 2024
This interactive article is reproduced with permission from EMJ. Discussion of the safety observations from the Phase 3 PROTECT and DUPLEX trials can be found in their respective publications.
MA-SP-26-0041 | April 2026